417 related articles for article (PubMed ID: 30753822)
1. UTX Mutations in Human Cancer.
Wang L; Shilatifard A
Cancer Cell; 2019 Feb; 35(2):168-176. PubMed ID: 30753822
[TBL] [Abstract][Full Text] [Related]
2. Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.
Kato H; Asamitsu K; Sun W; Kitajima S; Yoshizawa-Sugata N; Okamoto T; Masai H; Poellinger L
Oncogene; 2020 Apr; 39(16):3322-3335. PubMed ID: 32071397
[TBL] [Abstract][Full Text] [Related]
3. Lysine Demethylase KDM6A in Differentiation, Development, and Cancer.
Tran N; Broun A; Ge K
Mol Cell Biol; 2020 Sep; 40(20):. PubMed ID: 32817139
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.
Kim J; Lee SH; Jang JH; Kim MS; Lee EH; Kim YZ
J Neurosurg; 2017 May; 126(5):1461-1471. PubMed ID: 27367247
[TBL] [Abstract][Full Text] [Related]
5. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
6. The H3K27me3 demethylase UTX in normal development and disease.
Van der Meulen J; Speleman F; Van Vlierberghe P
Epigenetics; 2014 May; 9(5):658-68. PubMed ID: 24561908
[TBL] [Abstract][Full Text] [Related]
7. The Histone Demethylase UTX Promotes Brown Adipocyte Thermogenic Program Via Coordinated Regulation of H3K27 Demethylation and Acetylation.
Zha L; Li F; Wu R; Artinian L; Rehder V; Yu L; Liang H; Xue B; Shi H
J Biol Chem; 2015 Oct; 290(41):25151-63. PubMed ID: 26306033
[TBL] [Abstract][Full Text] [Related]
8. UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells.
Kim JH; Sharma A; Dhar SS; Lee SH; Gu B; Chan CH; Lin HK; Lee MG
Cancer Res; 2014 Mar; 74(6):1705-17. PubMed ID: 24491801
[TBL] [Abstract][Full Text] [Related]
9. Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.
Wang L; Zhao Z; Ozark PA; Fantini D; Marshall SA; Rendleman EJ; Cozzolino KA; Louis N; He X; Morgan MA; Takahashi YH; Collings CK; Smith ER; Ntziachristos P; Savas JN; Zou L; Hashizume R; Meeks JJ; Shilatifard A
Nat Med; 2018 Jun; 24(6):758-769. PubMed ID: 29785026
[TBL] [Abstract][Full Text] [Related]
10. The histone demethylase UTX/KDM6A in cancer: Progress and puzzles.
Schulz WA; Lang A; Koch J; Greife A
Int J Cancer; 2019 Aug; 145(3):614-620. PubMed ID: 30628063
[TBL] [Abstract][Full Text] [Related]
11. JMJD3 as an epigenetic regulator in development and disease.
Burchfield JS; Li Q; Wang HY; Wang RF
Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
[TBL] [Abstract][Full Text] [Related]
12. A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.
Wang SP; Tang Z; Chen CW; Shimada M; Koche RP; Wang LH; Nakadai T; Chramiec A; Krivtsov AV; Armstrong SA; Roeder RG
Mol Cell; 2017 Jul; 67(2):308-321.e6. PubMed ID: 28732206
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of E-cadherin expression by the histone demethylase UTX in colon cancer cells.
Zha L; Cao Q; Cui X; Li F; Liang H; Xue B; Shi H
Med Oncol; 2016 Mar; 33(3):21. PubMed ID: 26819089
[TBL] [Abstract][Full Text] [Related]
14. UTX demethylase activity is required for satellite cell-mediated muscle regeneration.
Faralli H; Wang C; Nakka K; Benyoucef A; Sebastian S; Zhuang L; Chu A; Palii CG; Liu C; Camellato B; Brand M; Ge K; Dilworth FJ
J Clin Invest; 2016 Apr; 126(4):1555-65. PubMed ID: 26999603
[TBL] [Abstract][Full Text] [Related]
15. Histone demethylase UTX is a therapeutic target for diabetic kidney disease.
Chen H; Huang Y; Zhu X; Liu C; Yuan Y; Su H; Zhang C; Liu C; Xiong M; Qu Y; Yun P; Zheng L; Huang K
J Physiol; 2019 Mar; 597(6):1643-1660. PubMed ID: 30516825
[TBL] [Abstract][Full Text] [Related]
16. Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.
Yi J; Shi X; Xuan Z; Wu J
Cancer Lett; 2021 Feb; 499():188-200. PubMed ID: 33253789
[TBL] [Abstract][Full Text] [Related]
17. Catalytic domain-dependent and -independent transcriptional activities of the tumour suppressor histone H3K27 demethylase UTX/KDM6A in specific cancer types.
Sun W; Lee KL; Poellinger L; Masai H; Kato H
Epigenetics; 2023 Dec; 18(1):2222245. PubMed ID: 37300822
[TBL] [Abstract][Full Text] [Related]
18. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming.
Mansour AA; Gafni O; Weinberger L; Zviran A; Ayyash M; Rais Y; Krupalnik V; Zerbib M; Amann-Zalcenstein D; Maza I; Geula S; Viukov S; Holtzman L; Pribluda A; Canaani E; Horn-Saban S; Amit I; Novershtern N; Hanna JH
Nature; 2012 Aug; 488(7411):409-13. PubMed ID: 22801502
[TBL] [Abstract][Full Text] [Related]
19. Histone demethylase Utx regulates differentiation and mineralization in osteoblasts.
Yang D; Okamura H; Teramachi J; Haneji T
J Cell Biochem; 2015 Nov; 116(11):2628-36. PubMed ID: 25920016
[TBL] [Abstract][Full Text] [Related]
20. UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development.
Shpargel KB; Sengoku T; Yokoyama S; Magnuson T
PLoS Genet; 2012 Sep; 8(9):e1002964. PubMed ID: 23028370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]